J Urol 2020 Jul
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study.
Related Questions
NGS of TURBT specimen had high TMB (18 Muts/Mb).
New comment by Medical Oncologist at AdventHealth Cancer Institute ( December 30, 2021)
I agree with trying the immune checkpoint inhibitor approach. Then, would consider Lurbinectedin- which is a cytotoxic agent approved for recurrent small cell lung cancer. Tri...